• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Intertek banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Propeller Health and GSK extend deal for use of Propeller sensor with Ellipta DPIs

Propeller Health and GSK have announced that their December 2015 agreement for development of a sensor for use with the Ellipta dry powder inhaler has been expanded, and R&D activities related to the use of the Propeller platform with GSK products for asthma and COPD will continue. The Propeller clip-on sensor for the Ellipta DPI received CE mark approval and 510(k) clearance in 2016.

According to the announcement, the purpose of the extended collaboration is “to prepare for and undertake commercial activities using the Propeller clip-on sensor and software platform for use with GSK’s Ellipta inhaler.”

Propeller Health CEO David Van Sickle commented, “We are excited to be working closely with GSK to make the sensor for the Ellipa inhaler available in our commercial programs, and for the first time, as part of commercial pilots with GSK outside the US. Companion digital experiences simplify and personalize the management of chronic respiratory disease, and help ensure individuals and their physicians realize the benefits of inhaled medicines.”

GSK Senior VP and Head, Global Respiratory Franchise, Eric Dube,said, “Digital innovations, like sensor technologies, will help us ensure patients receive the best possible package of care management and treatment for their respiratory condition. We are excited to expand our collaboration with Propeller as a further step in our journey towards achieving connected health systems for people with asthma and COPD.”

Earlier this year, Propeller Health announced a deal to develop a sensor for Novartis’s Breezhaler DPI.

Read the Propeller Health and GSK press release.

Share

published on August 24, 2017

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Bespak Leading the Green Transition banner
    © 2025 OINDPnews